IBDEI12M ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,18205,1,3,0)
 ;;=3^Cellulitis of Right Upper Limb
 ;;^UTILITY(U,$J,358.3,18205,1,4,0)
 ;;=4^L03.113
 ;;^UTILITY(U,$J,358.3,18205,2)
 ;;=^5009033
 ;;^UTILITY(U,$J,358.3,18206,0)
 ;;=I63.131^^79^874^43
 ;;^UTILITY(U,$J,358.3,18206,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18206,1,3,0)
 ;;=3^Cerebral Infarction d/t Right Carotid Artery Embolism
 ;;^UTILITY(U,$J,358.3,18206,1,4,0)
 ;;=4^I63.131
 ;;^UTILITY(U,$J,358.3,18206,2)
 ;;=^5007308
 ;;^UTILITY(U,$J,358.3,18207,0)
 ;;=I63.132^^79^874^41
 ;;^UTILITY(U,$J,358.3,18207,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18207,1,3,0)
 ;;=3^Cerebral Infarction d/t Left Carotid Artery Embolism
 ;;^UTILITY(U,$J,358.3,18207,1,4,0)
 ;;=4^I63.132
 ;;^UTILITY(U,$J,358.3,18207,2)
 ;;=^5007309
 ;;^UTILITY(U,$J,358.3,18208,0)
 ;;=I63.231^^79^874^44
 ;;^UTILITY(U,$J,358.3,18208,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18208,1,3,0)
 ;;=3^Cerebral Infarction d/t Right Carotid Artery Occlusion/Stenosis
 ;;^UTILITY(U,$J,358.3,18208,1,4,0)
 ;;=4^I63.231
 ;;^UTILITY(U,$J,358.3,18208,2)
 ;;=^5007316
 ;;^UTILITY(U,$J,358.3,18209,0)
 ;;=I63.232^^79^874^42
 ;;^UTILITY(U,$J,358.3,18209,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18209,1,3,0)
 ;;=3^Cerebral Infarction d/t Left Carotid Artery Occlusion/Stenosis
 ;;^UTILITY(U,$J,358.3,18209,1,4,0)
 ;;=4^I63.232
 ;;^UTILITY(U,$J,358.3,18209,2)
 ;;=^5007317
 ;;^UTILITY(U,$J,358.3,18210,0)
 ;;=N18.9^^79^874^46
 ;;^UTILITY(U,$J,358.3,18210,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18210,1,3,0)
 ;;=3^Chronic Kidney Disease,Unspec
 ;;^UTILITY(U,$J,358.3,18210,1,4,0)
 ;;=4^N18.9
 ;;^UTILITY(U,$J,358.3,18210,2)
 ;;=^332812
 ;;^UTILITY(U,$J,358.3,18211,0)
 ;;=K55.1^^79^874^49
 ;;^UTILITY(U,$J,358.3,18211,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18211,1,3,0)
 ;;=3^Chronic Vascular Intestinal Disorders
 ;;^UTILITY(U,$J,358.3,18211,1,4,0)
 ;;=4^K55.1
 ;;^UTILITY(U,$J,358.3,18211,2)
 ;;=^5008706
 ;;^UTILITY(U,$J,358.3,18212,0)
 ;;=I74.3^^79^874^96
 ;;^UTILITY(U,$J,358.3,18212,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18212,1,3,0)
 ;;=3^Embolism/Thrombosis of Lower Extremity Arteries
 ;;^UTILITY(U,$J,358.3,18212,1,4,0)
 ;;=4^I74.3
 ;;^UTILITY(U,$J,358.3,18212,2)
 ;;=^5007802
 ;;^UTILITY(U,$J,358.3,18213,0)
 ;;=I74.2^^79^874^108
 ;;^UTILITY(U,$J,358.3,18213,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18213,1,3,0)
 ;;=3^Embolism/Thrombosis of Upper Extremity Arteries
 ;;^UTILITY(U,$J,358.3,18213,1,4,0)
 ;;=4^I74.2
 ;;^UTILITY(U,$J,358.3,18213,2)
 ;;=^5007801
 ;;^UTILITY(U,$J,358.3,18214,0)
 ;;=N28.0^^79^874^109
 ;;^UTILITY(U,$J,358.3,18214,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18214,1,3,0)
 ;;=3^Ischemia/Infarction of Kidney
 ;;^UTILITY(U,$J,358.3,18214,1,4,0)
 ;;=4^N28.0
 ;;^UTILITY(U,$J,358.3,18214,2)
 ;;=^5015626
 ;;^UTILITY(U,$J,358.3,18215,0)
 ;;=S91.322A^^79^874^110
 ;;^UTILITY(U,$J,358.3,18215,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18215,1,3,0)
 ;;=3^Laceration w/ FB Left Foot,Init Encntr
 ;;^UTILITY(U,$J,358.3,18215,1,4,0)
 ;;=4^S91.322A
 ;;^UTILITY(U,$J,358.3,18215,2)
 ;;=^5137527
 ;;^UTILITY(U,$J,358.3,18216,0)
 ;;=S71.022A^^79^874^111
 ;;^UTILITY(U,$J,358.3,18216,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18216,1,3,0)
 ;;=3^Laceration w/ FB Left Hip,Init Encntr
 ;;^UTILITY(U,$J,358.3,18216,1,4,0)
 ;;=4^S71.022A
 ;;^UTILITY(U,$J,358.3,18216,2)
 ;;=^5136178
 ;;^UTILITY(U,$J,358.3,18217,0)
 ;;=S71.122A^^79^874^112
 ;;^UTILITY(U,$J,358.3,18217,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18217,1,3,0)
 ;;=3^Laceration w/ FB Left Thigh,Init Encntr
 ;;^UTILITY(U,$J,358.3,18217,1,4,0)
 ;;=4^S71.122A
